Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiac Output Response to Vasopressin in Major Abdominal Surgery Patients
2021-000841-42Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Mar 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2 trial of vasopressin in Cardiovascular collapse, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Cardiac output response to argipressin. Started Mar 2021; status: completed.
02
Drugs
vasopressin
03
Conditions
Cardiovascular collapse
Beyond the preview
Go deeper on 2021-000841-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000841-42.